Procedure
Flow Mediated Dilation
Flow Mediated Dilation is a medical procedure with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
unknown2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Impact of Regional Vibration Application and Flow Mediated Dilation on Brachial Artery Hemodynamics
NCT05492071
unknown
Flow Mediated Dilation in Association With Hyperuricemia
NCT05342285
unknown
Vascular Functions in Myeloma Patients During Anti-tumor Therapy
NCT03776331
completedphase_4
Mesoglycan, Vascular Reactivity and Metabolic Syndrome
NCT02254850
Clinical Trials (4)
Showing 4 of 4 trials
NCT05492071Not Applicable
Impact of Regional Vibration Application and Flow Mediated Dilation on Brachial Artery Hemodynamics
NCT05342285
Flow Mediated Dilation in Association With Hyperuricemia
NCT03776331
Vascular Functions in Myeloma Patients During Anti-tumor Therapy
NCT02254850Phase 4
Mesoglycan, Vascular Reactivity and Metabolic Syndrome
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4